Conning Inc. grew its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 4.9% during the 1st quarter, HoldingsChannel reports. The fund owned 4,710 shares of the company’s stock after acquiring an additional 220 shares during the quarter. Conning Inc.’s holdings in HCA Healthcare were worth $614,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of HCA. Chicago Equity Partners LLC grew its holdings in shares of HCA Healthcare by 4.6% in the fourth quarter. Chicago Equity Partners LLC now owns 1,841 shares of the company’s stock worth $229,000 after purchasing an additional 81 shares during the last quarter. Quadrant Capital Group LLC grew its holdings in shares of HCA Healthcare by 11.2% in the fourth quarter. Quadrant Capital Group LLC now owns 847 shares of the company’s stock worth $93,000 after purchasing an additional 85 shares during the last quarter. CWM LLC grew its holdings in shares of HCA Healthcare by 10.4% in the first quarter. CWM LLC now owns 1,181 shares of the company’s stock worth $154,000 after purchasing an additional 111 shares during the last quarter. Advisor Partners LLC grew its holdings in shares of HCA Healthcare by 2.3% in the fourth quarter. Advisor Partners LLC now owns 5,079 shares of the company’s stock worth $632,000 after purchasing an additional 113 shares during the last quarter. Finally, Commonwealth Bank of Australia grew its holdings in shares of HCA Healthcare by 4.6% in the fourth quarter. Commonwealth Bank of Australia now owns 2,783 shares of the company’s stock worth $344,000 after purchasing an additional 122 shares during the last quarter. 71.37% of the stock is currently owned by hedge funds and other institutional investors.
NYSE:HCA opened at $120.18 on Wednesday. The firm has a market capitalization of $40.08 billion, a P/E ratio of 12.30, a P/E/G ratio of 0.96 and a beta of 0.78. HCA Healthcare Inc has a twelve month low of $93.03 and a twelve month high of $147.42.
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 1st were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, February 28th. This represents a $1.60 annualized dividend and a yield of 1.33%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
Several research analysts have recently issued reports on HCA shares. Zacks Investment Research restated a “buy” rating and issued a $134.00 target price on shares of HCA Healthcare in a report on Monday, December 31st. Jefferies Financial Group set a $158.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, April 17th. SunTrust Banks raised their target price on shares of HCA Healthcare to $175.00 and gave the stock a “buy” rating in a report on Wednesday, January 30th. Deutsche Bank started coverage on shares of HCA Healthcare in a report on Thursday, January 3rd. They issued a “buy” rating and a $140.00 price target on the stock. Finally, ValuEngine cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eighteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $147.59.
In other HCA Healthcare news, SVP Deborah M. Reiner sold 523 shares of the firm’s stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $138.89, for a total transaction of $72,639.47. Following the completion of the transaction, the senior vice president now owns 4,927 shares of the company’s stock, valued at $684,311.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Bill B. Rutherford sold 37,500 shares of the firm’s stock in a transaction on Tuesday, February 12th. The shares were sold at an average price of $139.65, for a total value of $5,236,875.00. Following the transaction, the chief financial officer now directly owns 58,972 shares of the company’s stock, valued at approximately $8,235,439.80. The disclosure for this sale can be found here. Insiders have sold 78,476 shares of company stock valued at $10,940,008 in the last three months. Insiders own 2.70% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: Are all No-Load Funds Equal?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.